Distinguishing Cytolytic Vaginitis from Vulvovaginal Candidiasis
Cytolytic vaginosis (CV) is distinguished from vulvovaginal candidiasis (VVC) primarily by microscopy showing abundant lactobacilli with epithelial cytolysis and naked nuclei but no yeast forms, combined with low vaginal pH (≤4.5) and absence of fungal culture growth. 1, 2
Key Diagnostic Algorithm
Step 1: Measure Vaginal pH
- pH ≤4.5 (typically 3.8–4.2) narrows the differential to either CV or VVC, excluding bacterial vaginosis and trichomoniasis 1, 2
- Both conditions maintain acidic pH, so this alone cannot differentiate them 3
Step 2: Perform Wet Mount Microscopy with 10% KOH
This is the critical distinguishing step:
Findings favoring VVC:
- Presence of yeast forms, pseudohyphae, or true hyphae on KOH preparation 1
- Variable leukocyte count 1
- Intact epithelial cells 3
Findings favoring CV:
- Abundant lactobacilli (sensitivity 100%, specificity 56%) 2
- Epithelial cytolysis (fragmented epithelial cells; sensitivity 80%, specificity 99%) 2, 4
- Naked nuclei from lysed epithelial cells 5, 2
- "False clue cells" (epithelial cells covered with lactobacilli rather than Gardnerella) (sensitivity 70%, specificity 99%) 2
- Absent or minimal leukocytes 2, 4
- No yeast forms visible 3
Step 3: Obtain Fungal Culture with Speciation
- Mandatory when wet mount is negative but clinical suspicion for VVC remains 1
- Confirms absence of Candida species in CV 2, 4
- Detects non-albicans species and guides antifungal susceptibility testing in true VVC 1
- Critical caveat: PCR detection of Candida does not confirm active infection, as 20% of asymptomatic women are colonized 1
Clinical Presentation Overlap
Both conditions share similar symptoms, making clinical features alone unreliable for differentiation 3:
- Vaginal discharge (often white, thick, curd-like in both) 5, 3
- Pruritus 5
- Dysuria 5
- Dyspareunia 4
- Vaginal hyperemia 3
Key difference: VVC typically shows more intense inflammatory response with vulvar edema, erythema, excoriation, or fissures 1, 3
Common Diagnostic Pitfall
Over 55% of presumed VVC cases lack laboratory confirmation, leading to misdiagnosis of CV as VVC and inappropriate antifungal therapy 1. CV has a recurrence rate of 61.5% when misdiagnosed and treated with antifungals 5, because the underlying lactobacillus overgrowth remains untreated.
Prevalence Context
Recent studies show CV accounts for 19.4–32.1% of vaginitis cases 5, 2, making it far more common than historically recognized. The median prevalence is approximately 5% in symptomatic women 6.
Treatment Confirmation
If diagnostic uncertainty persists after microscopy and culture, therapeutic trial can confirm diagnosis: CV responds to sodium bicarbonate (NaHCO₃) sitz baths that raise vaginal pH 5, 4, whereas VVC requires antifungal therapy 7. Response to baking soda treatment with symptom resolution supports CV diagnosis retrospectively 4.